Drug recall · June 24, 2020
Gaviscon Extra Strength Liquid Antacid Extra Strength Cherry recall
Why: Labeling: Label lacks warning - Magnesium safety warning is not present on the Gaviscon bottle label.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Gaviscon Extra Strength Liquid Antacid Extra Strength Cherry, 12 FL OZ. (355 mL), Distributed by: GSK Consumer Healthcare Warren, NJ 07059, NDC 0135-0574-41
- Lots / codes
Lot #: 0A26C1, Exp 12/31/2021; 0B10C1, Exp 1/31/2022; 8L19C1, Exp 10/31/2020; 8L27C1, Exp 10/31/2020; 9A28C1, Exp 12/31/2020; 9B18C1, Exp 1/31/2021; 9C19C1, Exp 2/28/2021; 9D09C1, Exp 3/31/2021; 9F20C1, Exp 5/31/2021; 9G24C1, Exp 6/30/2021; 9J09C1, Exp 8/31/2021; 9K29C1, Exp 9/30/2021; 9L05C1, Exp 9/30/2021
- Quantity
- 629,796 bottles
- Company
- Glaxosmithkline Consumer Healthcare Holdings, Warren, NJ
- Distribution
- U.S.A. Nationwide
- Initiated
- May 28, 2020 · Voluntary: Firm initiated
- Classified
- June 18, 2020
- Reported
- June 24, 2020
- Ended
- January 24, 2022
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.